galantamine has been researched along with Chromosome Deletion in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balañá, G; Casas-Alba, D; Díez-Juan, M; Fons, C; Mezzatesta, M; Nolasco, GA | 1 |
| Adam, MP; Cubells, JF; Deoreo, EH; Garber, K; Garlow, SJ; Harvey, PD; Martin, CL | 1 |
2 other study(ies) available for galantamine and Chromosome Deletion
| Article | Year |
|---|---|
Targeted therapy with galantamine in a pediatric patient with 15q13.3 deletion syndrome.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Child, Preschool; Chromosome Deletion; Chromosome Disorders; Chromosomes, Human, Pair 15; Female; Galantamine; Humans; Intellectual Disability; Molecular Targeted Therapy; Pediatrics; Seizures | 2021 |
Pharmaco-genetically guided treatment of recurrent rage outbursts in an adult male with 15q13.3 deletion syndrome.
Topics: Adult; Cholinesterase Inhibitors; Chromosome Deletion; Chromosomes, Human, Pair 15; Epilepsy; Female; Galantamine; Humans; Male; Mental Disorders; Pharmacogenetics; Phenotype; Rage; Schizophrenia; Syndrome | 2011 |